New targets for pharmacological intervention in the glutamatergic synapse
about
Memantine inhibits α3β2-nAChRs-mediated nitrergic neurogenic vasodilation in porcine basilar arteriesDifferential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatmentNMDA Receptor Function During Senescence: Implication on Cognitive PerformanceTAAR1 Modulates Cortical Glutamate NMDA Receptor Function.PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor traffickingTreatment with Piribedil and Memantine Reduces Noise-Induced Loss of Inner Hair Cell Synaptic RibbonsNeuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice.Role of the proteasome in excitotoxicity-induced cleavage of glutamic acid decarboxylase in cultured hippocampal neurons.Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.Glutamate receptors as seen by light: spectroscopic studies of structure-function relationships.Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicityFunctional NMDA receptors with atypical properties are expressed in podocytesAlzheimer's disease and metals: a review of the involvement of cellular membrane receptors in metallosignalling.Vascular cognitive impairment: disease mechanisms and therapeutic implications.Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.NMDA di-heteromeric receptor populations and associated proteins in rat hippocampusReversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.SOD activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure-activity study.Evaluating the efficacy of memantine on improving cognitive functions in epileptic patients receiving anti-epileptic drugs: A double-blind placebo-controlled clinical trial (Phase IIIb pilot study).Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation.Glypican 6 Enhances N-Methyl-D-Aspartate Receptor Function in Human-Induced Pluripotent Stem Cell-Derived Neurons.Selective vulnerability of hippocampal cornu ammonis 1 pyramidal cells to excitotoxic insult is associated with the expression of polyamine-sensitive N-methyl-D-asparate-type glutamate receptors.Emerging cognitive enhancing drugs.Treatment of status epilepticus with ketamine, are we there yet?A microdialysis and enzymatic reactor sensing procedure for the simultaneous registration of online glutamate measurements at high temporal resolution during epileptiform activity.Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions.Novel glycine-dependent inactivation of NMDA receptors in cultured hippocampal neurons.Altered sensitivity to excitotoxic cell death and glutamate receptor expression between two commonly studied mouse strains.Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones.Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/reperfusion in rats.Acupuncture attenuates extracellular glutamate level in global ischemia model of rat.Design and synthesis of highly potent and plasma-stable dimeric inhibitors of the PSD-95-NMDA receptor interaction.NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity.The role of NMDA receptor subtypes in short-term plasticity in the rat entorhinal cortex.1H MRSI and social communication deficits in pediatric complex partial seizures.The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease.Anxiogenic-like profile of Wistar adult rats based on the pilocarpine model: an animal model for trait anxiety?Effect of pleiotrophin on glutamate-induced neurotoxicity in cultured hippocampal neurons.Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function
P2860
Q21134148-691A7A92-92EC-4523-98B8-0F7DEF5B43F9Q24684364-5FD46FA8-E20F-4B69-8AD9-C71591C61678Q26770902-930EF5E2-EED3-425B-8405-B2A5407F5399Q27310661-94A8A554-CD9B-47B9-B1E9-1BA885DD0613Q28582674-7347ECC8-945C-4DE7-BC43-E47FFA79EBA1Q30373472-EF6C5477-9FDB-47C9-9345-B7B16E544D6EQ30478676-67A1E2BC-4EA7-4E16-B783-6D9EC3D35094Q33559884-6CAF47E3-CCE6-4902-A0C5-8EE9B320BBFEQ33595930-C40D0E7A-FEB7-446C-B4AD-BF5EC15119EAQ33681057-A1216835-FA8A-4F54-BAFE-FFA87D3B1ED1Q34273861-AEE49E7F-3B45-4FC1-B42D-A51E927A90DDQ34501710-309D209F-454D-49B3-9597-AE30BEAE9D27Q34725385-512C85A7-E79D-423D-BE12-0014FCABDFEFQ35197111-89C01640-8F45-45AF-9C55-F8B057AA1DBCQ35840603-DD156717-7709-4F56-AF65-264A95397325Q36310524-B561F944-229C-4E06-8B95-D3B10065CDC3Q36489185-0BD05ACF-27AF-4281-88EE-B80DEC44E3F4Q36494558-4968CCC9-33DA-4382-82AA-D46330A4C052Q37118859-A4328FD3-D371-4D8C-93E1-FE233A00C041Q37167364-DEF0022B-DF3E-4BAB-BCDB-6C702759D0D9Q37227959-E46587DB-B385-4ED6-8073-CB83040A518CQ37413408-F09EA3CE-4B27-43FC-AB05-6780313AF032Q37480137-54BECE54-194A-403A-9F04-83EA73A6D35CQ37601479-5EFEE704-203C-4C60-AC2B-EABAB59EE70BQ38100382-A44E0BF3-12BE-49F2-8933-1395C418B54FQ39369935-28A9776B-2936-40B9-8B3E-B989709F75F1Q40733593-0A337A75-FE6A-46A8-9564-3E3C6FE8F419Q41453410-8173BCF4-EDC7-47D3-926B-EC8B4EA13D6CQ42071665-DB5BD0DF-B262-4F62-B640-20CB568D40C9Q42474084-6F1E90FB-100D-4636-9B78-81C08B5F2AAAQ42838069-73A758C9-0F7F-409C-AE3B-D4AE45E56C2FQ43208143-2509355F-8796-483E-8868-F73F5D7CF104Q43235877-51A19C59-A07C-4C07-B184-B5E3880C357BQ43243037-64E2368E-2DAB-4B5F-81A1-4FF1081748F4Q43247737-4711E55C-1A17-48A3-9377-1394BDB846F5Q46251191-14C1719F-269A-4C7F-A89F-8DB860DF34E5Q47918037-5D7B0E0D-70C2-4C77-9D53-39751726A610Q48233177-59CBEA0E-C575-4BD4-A4F4-D45DA626A3EAQ48891607-9F09742A-38E7-4FA6-B0C1-128D5A41AF45Q57177748-64C38C8B-CB7D-4DF2-9C48-BB5B62AE851B
P2860
New targets for pharmacological intervention in the glutamatergic synapse
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
New targets for pharmacological intervention in the glutamatergic synapse
@ast
New targets for pharmacological intervention in the glutamatergic synapse
@en
New targets for pharmacological intervention in the glutamatergic synapse
@nl
type
label
New targets for pharmacological intervention in the glutamatergic synapse
@ast
New targets for pharmacological intervention in the glutamatergic synapse
@en
New targets for pharmacological intervention in the glutamatergic synapse
@nl
prefLabel
New targets for pharmacological intervention in the glutamatergic synapse
@ast
New targets for pharmacological intervention in the glutamatergic synapse
@en
New targets for pharmacological intervention in the glutamatergic synapse
@nl
P3181
P1476
New targets for pharmacological intervention in the glutamatergic synapse
@en
P2093
Fabrizio Gardoni
Monica Di Luca
P3181
P356
10.1016/J.EJPHAR.2006.06.022
P407
P577
2006-06-15T00:00:00Z